Amyloid Beta 25–35 induces blood-brain barrier disruption in vitro

Overview of attention for article published in Metabolic Brain Disease, July 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#35 of 1,118)
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news: 1 news outlet
twitter: 3 X users

patent: 2 patents

Citations

dimensions_citation: 37 Dimensions

Readers on

mendeley: 41 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 1,628 followers.

RT @Biosensis: This study by Cuevas et al. suggests that Aβ25–35 (the toxic domain of #Aβ) induces Blood-Brain Barrier (BBB) dysfunction in…

10 Jul 2019

Reply Repost Favourite

This study by Cuevas et al. suggests that Aβ25–35 (the toxic domain of #Aβ) induces Blood-Brain Barrier (BBB) dysfunction in vitro, which ultimately leads to disruption of BBB integrity and cell death. https://t.co/517jTHDnge . Biosensis' MOAB 2 antibody (

10 Jul 2019

Reply Repost Favourite

Amyloid Beta 25-35 induces blood-brain barrier disruption in vitro. https://t.co/LjcMlDBoX3

04 Jul 2019

Reply Repost Favourite